| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 3.1, positive 3.6, negative -0.5) on 20251007. The forces of Sentiment towards Fundamentals (2.2), Price Level (2), Option Speculation (1.5), Sector Price Trend (1.2), Broad Market Trend (0.2), and Valuation Sentiment (-1) will drive up the price. The forces of and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.6). The extreme bullish overall sentiment (3.1) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-07 | 2% | 1.4% | 144.24 | 92 | 0.1% | 0.5% | 2.1 | 1.2 | 2.2 | 2.4 |
| 2025-10-06 | 1% | 1.4% | 144.1 | 97 | -0.48% | 0.58% | 2.6 | 1.7 | 2.5 | 6 |
| 2025-10-05 | 0% | 1.4% | 2.2 | 1.8 | 2 | 0 | ||||
| 2025-10-04 | 1% | 1.6% | 2.2 | 1.8 | 2 | 0 | ||||
| 2025-10-03 | 2% | 1.4% | 144.8 | 112 | 1.15% | 0.51% | 2.3 | 1.8 | 2.2 | 4.3 |
| 2025-10-02 | 2% | 1.3% | 143.16 | 111 | -0.16% | 0.44% | 1.8 | 1.2 | 2 | 2.7 |
| 2025-10-01 | 2% | 1.3% | 143.39 | 132 | 3.01% | 0.44% | 0.6 | 1 | 1.5 | 6.6 |
| 2025-09-30 | 2% | 1.1% | 139.2 | 92 | 2.43% | 0.22% | 1.2 | 0.3 | 1.5 | 5.6 |
| 2025-09-29 | 1% | 1% | 135.9 | 23 | 0.28% | -0.07% | 0.8 | -0.2 | 1.2 | 1.3 |
| 2025-09-28 | 1% | 1.4% | 0.3 | -0.3 | 0.6 | 7 | ||||
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (-8) J&J Must Pay Record $966 Million in Talc Baby Powder Cancer Case Johnson & Johnson was told by a California jury to pay $966 million to the family of a deceased woman who blamed her cancer on life-long use of the company’s baby powder in the largest verdict for a single user in the 15-year litigation. (https://www.bloomberg.com/) Tue. Oct 7, 2025 | |
| 2 (5) Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers Amgen is the latest drugmaker to sell certain drugs directly to consumers amid pressure from President Donald Trump. Meanwhile, Dr. Oz talks GLP-1s for obesity. (https://www.cnbc.com/) Tue. Oct 7, 2025 | |
| 3 (6) The top 10 jobs employers are hiring for right now, according to a new Monster report Health care positions led the charge in Monster's top 10 hottest jobs right now, but logistics and customer service roles also made the cut. (https://www.cnbc.com/) Tue. Oct 7, 2025 | |
| 4 (5) Medicare open enrollment kicks off Oct. 15: What to know Medicare open enrollment opens on Oct. 15 and ends on Dec. 7. During this period, beneficiaries are able to change their coverage. Robert Powell, host of Yahoo Finance's Decoding Retirement podcast, outlines what to watch for as people receive their Annual Notice of Change (ANOC), how to navigate Medicare's plan compare, and more. For more tips on navigating Medicare open enrollment, check out Yahoo Finance's weeklong Decoding Retirement special, starting Monday, Oct. 13. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime. (https://finance.yahoo.com/) Tue. Oct 7, 2025 | |
| 5 (0) Looking At Eli Lilly's Recent Unusual Options Activity (https://www.benzinga.com/) Tue. Oct 7, 2025 | |
| 6 (1) A healthcare compromise could end the shutdown. The question is when. A week of shutdown bluster has offered repeated signs that reviving expiring Affordable Care Act subsidies could be a way out. The problem is one of timing. (https://finance.yahoo.com/) Tue. Oct 7, 2025 | |
| 7 (8) EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial Envoy Medical secured FDA approval to expand its Acclaim cochlear implant trial, accelerating timelines and reducing capital needs by up to $15 million. (https://www.benzinga.com/) Tue. Oct 7, 2025 | |
| 8 (6) Pro traders are watching Pfizer after a big move last week and two other stocks with earnings on deck Jay Woods, chief market strategist at Freedom Capital Markets, highlighted a few beaten-down names that could become strong buying opportunities. (https://www.cnbc.com/) Mon. Oct 6, 2025 | |
| 9 (5) An options strategy that bets on this medical device stock catching up to the rest of the market Options trader Michael Khouw breaks down this trade on a medical devices maker. (https://www.cnbc.com/) Mon. Oct 6, 2025 | |
| 10 (7) AstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapies Under the deal, AstraZeneca will get exclusive rights to develop therapies that target immune system-related disorders. The Anglo-Swedish pharmaceutical major will also get the right to sell the treatments, if they get approved, while Algen will get upfront and milestone payments. AstraZeneca has been advancing its cell and gene therapy capabilities through acquisitions and partnerships as it works towards its target of $80 billion in sales by 2030. (https://finance.yahoo.com/) Mon. Oct 6, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA